Interview John Soloninka, President & CEO, HTX, Canada
John Soloninka, President & CEO of HTX, talks about his vast experience in the pharmaceutical and healthcare sector, why he feels there is much room for growth in Canada still,…
Servier Canada Inc is the Canadian affiliate of The Servier Research Group, a leading French research based organisation, specializing in ethical pharmaceuticals.
In the short span of fifty five years, the Servier Research Group has developed in stature from a family-owned, provincial pharmacy employing nine people to a multi-national operation with over 20,000 employees, including 3,000 in R&D, yet the Company is still privately-owned and is still passionately and permanently committed to remaining independent.
In Canada, Servier’s activities commenced in February 1978 in a modest location in Pointe-Claire, Quebec with a total staff of three employees. Within a month of its opening, a Sales supervisor and seven sales representatives were recruited and working in the region of Quebec. From 1985-1991, Servier Canada continued to gradually expand its presence across Canada, with growth in both its size of sales force and the number of head office employees. By 1994, the Company had moved to new premises in Laval, Quebec, where its current facility resides.
Servier Canada is committed to the investment in research and development and was proud to join Canada’s Research Based Pharmaceutical Companies (Rx&D) in 1995.
Contact
John Soloninka, President & CEO of HTX, talks about his vast experience in the pharmaceutical and healthcare sector, why he feels there is much room for growth in Canada still,…
Pierre Montanaro, President and CEO of Pharmetics, discusses the history of his company’s work in the private label business and future plans to expand into a wider variety of areas…
David Goodman, CEO of Pharmascience, describes the importance of balancing innovation with low cost products in Canada and outlines his company’s strategy for growth domestically and internationally. 2013 marks the…
John Soloninka, President & CEO of HTX, talks about his vast experience in the pharmaceutical and healthcare sector, why he feels there is much room for growth in Canada still,…
Pierre Montanaro, President and CEO of Pharmetics, discusses the history of his company’s work in the private label business and future plans to expand into a wider variety of areas…
Wendy Adams, General Manager of Galderma Canada, speaks about the importance of the Canadian market for the global company, what sets Galderma apart from its competitors, and where she sees…
Despite declining investments by big pharma in recent years, Canada has created a number of innovative ways to incentivize R&D throughout its vast geography. “Science powers commerce,” Canadian Prime Minister…
Deborah Brown, President of EMD Serono Canada, talks about Canada’s emerging market mentality, despite being a developed country, and how this lack of innovation and risk-taking could ultimately break Canada’s…
The president of Brancorth Medical talks about the challenges of the start-up med tech scene in Canada, turning innovation into corporate success, and the role of the government in creating…
Mr. Lebrun discusses the role that BIOQuébec plays in the industry, its aims in representing several sectors and their plans for the coming years. Could you introduce BIOQuébec and its…
Riaz Bandali, President ESD of InVentiv Health Clinical discusses the ways in which the company’s unique combination of different technologies and capabilities will help lead the way to better healthcare…
Tony Cruz of Transition Therapeutics discusses the challenges of biotech companies in Canada and his company’s unique business model that has adapted to the changing needs of big pharma through…
See our Cookie Privacy Policy Here
